OCT 12, 2021 5:30 AM PDT

Major Landmark in a 100-Year Search for a Malaria Vaccine

WRITTEN BY: Tara Fernandez

In one of the greatest global health milestones of our time, the World Health Organization has approved the widespread distribution of the world’s first malaria vaccine. This move, say researchers and public health groups, is a historic moment in the battle against malaria—a preventable and treatable disease that kills over 400 000 people a year. In Africa, the majority of these victims are children under the age of 5.

The endorsed vaccine, called Mosquirix, is the first and only treatment on the market shown to reduce the risk of infection and death in young children. The malarial parasite, P. falciparum, tops the list as the most deadly parasitic pathogen and is spread via a female Anopheles mosquito bite.

From an immunological perspective, malaria is particularly difficult to treat. The parasite has evolved clever ways of evading the immune system. For example, malaria-infected red blood cells stick onto non-infected cells, forming flower-shaped ‘rosettes’. These rosettes camouflage the parasites as they hide away from circulating immune cells. 

Mosquirix contains a protein fragment from P. falciparum, alongside another derived from the hepatitis B virus, a unique combo designed to provoke a stronger immune response. If an infected mosquito bites a vaccinated individual, the parasite’s entry into the liver (the organ where it matures and divides) will be blocked.

The WHO is basing their decision on data collected in previous clinical trials, the largest of which involved over 800,000 children across three African countries. These studies found Mosquirix to be safe and helped protect children in regions with moderate to high malarial rates.

However, the efficacy of protection has raised doubts among some experts. The vaccine only lowered the rate of hospitalization from malaria by around 30 percent. Additionally, the entire course of treatment requires four injections over 18 months, starting when infants are about six months old. In addition, despite discounts offered by the manufacturer, GlaxoSmithKline, a cost of $5 per shot may be prohibitive to families in the region. 

Still, this marks the end of a 100-year hunt for a malarial vaccine. With a carefully considered rollout plan, Mosquirix has the potential to save thousands of lives in malaria-affected geographies.

 


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JUN 29, 2021
Immunology
The Heartbreaking Nature of COVID Revealed
JUN 29, 2021
The Heartbreaking Nature of COVID Revealed
Researchers at the Washington University School are getting to the root of heart damage resulting from COVID-19 infectio ...
JUL 15, 2021
Immunology
Your Immune System Can't Deal With All the Plastic You're Eating
JUL 15, 2021
Your Immune System Can't Deal With All the Plastic You're Eating
Microplastics—tiny fragments of plastic, less than five millimeters in diameter—pollute our environment and, ...
JUL 18, 2021
Cancer
Light Alcohol Use Linked to Higher Cancer Risk
JUL 18, 2021
Light Alcohol Use Linked to Higher Cancer Risk
Moderate alcohol use is linked to a substantially higher risk of several forms of cancer, including breast, colon, and o ...
JUL 29, 2021
Drug Discovery & Development
What is Ivermectin and Can it Treat COVID?
JUL 29, 2021
What is Ivermectin and Can it Treat COVID?
Lab tests in 2020 found that the widely available drug ivermectin had a weak effect on the SARS-CoV-2 virus and that unf ...
AUG 24, 2021
Health & Medicine
Myocarditis and COVID-19 Vaccination
AUG 24, 2021
Myocarditis and COVID-19 Vaccination
Myocarditis has been linked to sudden cardiac death in young, healthy athletes and smallpox, influenza, hepatitis B, and ...
AUG 27, 2021
Health & Medicine
Blood Group and COVID-19 Susceptibility- An Ongoing Debate
AUG 27, 2021
Blood Group and COVID-19 Susceptibility- An Ongoing Debate
Since their discovery, there has been an interest in how ABO blood groups and infectious diseases may be related. In add ...
Loading Comments...